Compare GBCI & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GBCI | BRKR |
|---|---|---|
| Founded | 1955 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.7B |
| IPO Year | 1996 | 2000 |
| Metric | GBCI | BRKR |
|---|---|---|
| Price | $51.98 | $58.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 13 |
| Target Price | ★ $54.00 | $48.54 |
| AVG Volume (30 Days) | 1.2M | ★ 2.2M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.74% | 0.58% |
| EPS Growth | ★ 18.45 | N/A |
| EPS | ★ 0.63 | 0.02 |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | $31.52 | $6.30 |
| Revenue Next Year | $8.46 | $3.81 |
| P/E Ratio | ★ $83.38 | $3,070.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $39.90 | $28.53 |
| 52 Week High | $53.99 | $64.54 |
| Indicator | GBCI | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 62.69 | 54.81 |
| Support Level | $47.29 | $52.90 |
| Resistance Level | $53.99 | $64.54 |
| Average True Range (ATR) | 1.19 | 2.45 |
| MACD | 0.23 | -0.30 |
| Stochastic Oscillator | 81.39 | 44.70 |
Glacier Bancorp Inc is a regional bank holding company providing commercial banking services through its wholly owned bank subsidiary, Glacier Bank. The group provides a full range of banking services to individuals, small to medium-sized businesses, community organizations, and public entities from several locations in Montana, Idaho, Utah, Washington, Wyoming, Colorado, Arizona, Nevada, and Texas. It offers various banking products and services, including: retail banking, business banking, real estate, commercial, agriculture, and consumer loans; and mortgage origination and loan servicing services, among others.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.